A Calcium-Related Immune Signature in Prognosis Prediction of Patients With Glioma

Cha Lin, Jian Chen, Zhaoying Su, Pei Liu, Zheyu Liu, Chen Ouyang, Dan Xu, Lin Zhong-da, Xu Pei, Ganqiang Liu, Xinjian LiuFrontiers in Cell and Developmental Biology 2021 · DOI

Abstract

Background: While immune checkpoint inhibitors have transformed cancer therapy, their efficacy in gliomas remains limited. This study aims to identify gene expression signatures related to glioma prognosis and construct a predictive model for patient survival. Methods: Calcium-related differentially expressed genes (DEGs) were analyzed across two independent databases (TCGA and Wang et al.). An 18-gene prognostic signature was developed using Cox regression and validated across multiple cohorts. The relationship between this signature and the tumor microenvironment (TME) was evaluated using the CIBERSORT algorithm. Results: A 415-gene intersection of DEGs was identified, with the calcium signaling pathway being significantly enriched. A risk score derived from the 18-gene signature effectively stratified patients into high- and low-risk groups. High-risk scores correlated with worse outcomes, characteristic clinical features (e.g., IDH-wildtype), and markers of T-cell exhaustion (PD-1, LAG3, TIM-3). Conclusion: Calcium signaling is deeply linked to immunosuppression in gliomas. Targeting this pathway may offer a new strategy to improve immunotherapy efficacy.

Introduction

Gliomas are the most common and aggressive primary brain tumors, characterized by high morbidity and poor prognosis. Despite standard treatments including surgery and chemo-radiotherapy, survival rates remain low. Immunotherapy, particularly immune checkpoint blockade, has failed to achieve significant breakthroughs in gliomas due to the highly immunosuppressive "cold" tumor microenvironment (TME). Identifying the genetic drivers of this immunosuppression is critical for developing better prognostic tools and therapeutic strategies.

To uncover the molecular basis of glioma progression, researchers performed a comprehensive bioinformatics analysis of large-scale datasets. By comparing glioma tissues with normal brain tissues in the TCGA and Wang et al. cohorts, they identified a core set of 415 differentially expressed genes (DEGs).

Identification of DEGs and pathway enrichment analysis. (A) Venn diagram showing the intersection of 415 DEGs between datasets. (B) Volcano plot of DEGs. (C) Dot plot showing significant enrichment of the Calcium Signaling Pathway. (D) GSEA plot confirming the response to calcium ions in tumor vs. normal tissue.

Functional enrichment analysis revealed that these genes were most significantly involved in the calcium signaling pathway. Calcium ions are vital secondary messengers that regulate diverse cellular processes, including proliferation and immune response. From this pool, an 18-gene panel was selected using Univariate and Multivariate Cox regression to construct a prognostic risk score.

The Calcium-Immune Axis and the Tumor Microenvironment

A central finding of this study is the profound connection between disrupted calcium signaling and the immune landscape of gliomas. The researchers discovered that low expression of the 18 calcium-related genes (resulting in a high-risk score) was strongly associated with an immunosuppressive environment.

Key observations included:

  • T-cell Exhaustion: High-risk scores significantly correlated with increased expression of exhausted T-cell markers, such as PD-1, LAG3, and TIM-3. This suggests that while immune cells may be present in the tumor, they are functionally inactive.
  • Macrophage Polarization: High-risk tumors were heavily infiltrated by M2 macrophages, which promote tumor growth and suppress anti-tumor immunity, rather than the tumor-attacking M1 phenotype.
  • Immunosuppressive Signaling: The data indicates that the calcium signaling pathway plays a regulatory role in maintaining the "cold" TME that allows gliomas to evade the immune system.

Clinical Utility and Prognostic Power

The 18-gene risk score proved to be a robust independent prognostic factor. In validation cohorts, the model achieved high predictive accuracy, with an Area Under the Curve (AUC) of 0.791 at two years. Patients in the low-risk group had significantly longer overall survival compared to those in the high-risk group across all datasets (p < 0.001).

To translate these findings into clinical practice, the authors developed a nomogram that integrates the risk score with traditional clinical markers like age and IDH mutation status. This tool achieved a C-index of 0.743, providing clinicians with a reliable method for predicting 1-, 2-, and 3-year survival probabilities.

Conclusion

This study establishes the calcium signaling pathway as a critical regulator of the glioma immune microenvironment and a powerful predictor of patient prognosis. The identified 18-gene signature not only offers a new tool for risk stratification but also highlights calcium signaling as a potential therapeutic target. Reversing the calcium-mediated immunosuppression could be the key to "thawing" the cold microenvironment of gliomas and improving the success of immunotherapy.

Summary updated

Abstract

<b>Background:</b> Immune checkpoint inhibitors have been successfully used in a variety of tumors, however, the efficacy of immune checkpoint blockade therapy for patients with glioma is limited. In this study, we tried to clarify gene expression signatures related to the prognosis of gliomas and construct a signature to predict the survival of patients with gliomas. <b>Methods:</b> Calcium-related differential expressed genes (DEGs) between gliomas and normal brain tissues were comprehensively analyzed in two independent databases. Univariate, multivariate Cox regression analysis and proportional hazards model were used to identify the prognostic of calcium-related risk score signature. The CIBERSORT algorithm and association analysis were carried out to evaluate the relationship between calcium-related signature and characteristic clinical features, tumor-infiltrating immune cell signatures as well as immune checkpoint molecules in glioma. A nomogram model was developed for predicting the overall survival for patients with gliomas. <b>Results:</b> We found the intersection of 415 DEGs between gliomas and normal brain tissues, and identified that an eighteen calcium-related gene panel was significantly enriched in these DEGs. A calcium-related signature derived risk score was developed to divide patients into high- and low-risk groups. Low levels of calcium-related gene expression in high-risk score cases were accompanied with worse outcomes of patients. Calcium-related risk scores were significantly associated with characteristic clinical features, immune infiltrating signatures of tumor microenvironment, and exhausted T cell markers including programmed cell death 1 (PD-1), lymphocyte activating 3 (LAG3), and T cell membrane protein 3 (TIM-3), which contribute to an adverse therapeutic effect of immunotherapy. Calcium-related signature risk score was considered as an independent prognostic parameter to predict the of overall survival of patients with gliomas in nomogram model. <b>Conclusion:</b> Our study demonstrated that calcium signaling pathway is highly associated with immunosuppression of gliomas and overall survival of patients. Targeting the calcium signaling pathway might be a new strategy to reverse the immunosuppressive microenvironment of gliomas and improve the efficacy of glioma immunotherapy.
BibTeX
@inproceedings{lin2021calcium,
  author = {Cha Lin and Jian Chen and Zhaoying Su and Pei Liu and Zheyu Liu and Chen Ouyang and Dan Xu and Lin Zhong-da and Xu Pei and Ganqiang Liu and Xinjian Liu},
  title = {{A Calcium-Related Immune Signature in Prognosis Prediction of Patients With Glioma}},
  booktitle = {Frontiers in Cell and Developmental Biology},
  year = {2021},
  doi = {10.3389/fcell.2021.723103},
}
Figure